Working with industry will get us there faster than blunt-force regulation.

The government can't combat this problem alone. Seniors can do a lot to protect themselves and the system. And we should all be alert for scams.

In an exclusive interview with Yahoo Finance's Decoding Retirement podcast, Mehmet Oz, the administrator of the Centers for ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Dr. Mehmet Oz and former U.S. Senator Bill Frist meet in Nashville for a fireside chat to discuss the evolving Medicaid ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

Nashville's health care leaders gathered July 22 to hear a discussion between Dr. Bill Frist and Dr. Mehmet Oz, the new ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...